chrisvos

Aperam Q3 EBITDA lower than expected, overall outlook still up

Long
EURONEXT:APAM   APERAM
The revenue of Aperam in Q3 showed us lower ebitda/revenue than analysts expected. Still they managed to reduce debt and the outlook for Q4 is positive. Today a gap of -8% and it already filled the gap all the way up the opening. For now I anticipate on more upside.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.